Biostax Corp (BTAX)

[locicat1]

Your consistent indications regarding the proper PR from IMUN are, in general, on target but I firmly believe that the ongoing persistent deficiency in promulgating the company's accomplishments and positive outlines of planned future projects with valid endpoints is a matter of, alarmingly,"nothing there". Just one example to start-Here is a company that twice, not once, but twice over five years had a meeting with the FDA to consider moving forward its IND with late Phase 1/Phase 2 Clinical studies for a patented indication in a disease state still in need of relevant and effective drugs. What happened? Where is the highly touted John Abeles, M.D.? Where is the funding?When will the studies start? There can be no truthful PR until "somethings there".

With all the potential therapeutic uses for LDN and MENK--where are the true FDA clinical studies? Why have they not been started over the last five years? NOT ONE! Screaming for PR about what?? Announcements go out-but nothing of any substantive progress ensues. Why? Answer is simple-but let's see who can provide the no doubt correct one.